Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

S7135

Sigma-Aldrich

Span® 85

Sinónimos:

Sorbitane trioleate

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Número de CAS:
26266-58-0
EC Number:
247-569-3
MDL number:
MFCD00133820
UNSPSC Code:
12161900
PubChem Substance ID:
24899734
NACRES:
NA.25

description

non-ionic

Quality Level

200

mol wt

957.52 g/mol

solubility

chloroform: 50 mg/mL, clear, faintly to light yellow

HLB

1.8

SMILES string

CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC(=O)CCCCCCC\C=C\CCCCCCCC

InChI

1S/C60H108O8/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-56(62)65-52-54(61)59-60(68-58(64)51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)55(53-66-59)67-57(63)50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h25-30,54-55,59-61H,4-24,31-53H2,1-3H3/b28-25-,29-26-,30-27+/t54-,55+,59-,60-/m1/s1

InChI key

ZBNRGEMZNWHCGA-WECPCUOASA-N

Categorías relacionadas

General description

Sorbitane trioleate, or Span 85, is a non-ionic detergent.

Application

Sorbitane trioleate, or Span 85, has been used in a study to develop a novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants. It has also been used in a study to analyze the application of liquid chromatography in polymer non-ionic antistatic additives.

Other Notes

Fatty acid composition: Oleic acid (C18:1) ≥ 60%; linoleic acid (C18:2) 3 - 12%; linolenic acid (C18:2) ≤ 3%; palmitoleic acid (C16:1) 2 - 6%; balance primarily palmitic acid (C16:0).

Legal Information

Span is a registered trademark of Croda International PLC

Storage Class

10 - Combustible liquids

wgk_germany

WGK 1

flash_point_f

437.0 °F

flash_point_c

225 °C

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
MKCX0131
0000407470
0000400070
0000400071
0000337195

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 7

1 of 7

Span® 80 for synthesis

Sigma-Aldrich

8.40123

Span® 80

Sorbitan monopalmitate

Sigma-Aldrich

388920

Sorbitan monopalmitate

TWEEN® 65

Sigma-Aldrich

P3190

TWEEN® 65

Span® 60 for synthesis

Sigma-Aldrich

8.40121

Span® 60

Span® 80 suitable for GC

Supelco

09569

Span® 80

TWEEN® 80 viscous liquid

Sigma-Aldrich

P1754

TWEEN® 80

TWEEN® 60 nonionic detergent

Sigma-Aldrich

P1629

TWEEN® 60

M Victoria González-Rodríguez et al.
Journal of separation science, 33(22), 3595-3603 (2010-10-12)
This article investigates the applicability of HPLC-UV, ultra performance LC-evaporative light-scattering detection (UPLC-ELSD), HPLC-ESI(+)-MS and HPLC-hybrid linear ion trap (LTQ) Orbitrap MS for the analysis of different non-ionic antistatic additives, Span 20, Span 60, Span 65, Span 80, Span 85
A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants
Tan, Y., et al.
International Journal of Pharmaceutics, 413, 7-7 (2011)
Yang Liu et al.
Journal of colloid and interface science, 290(1), 259-266 (2005-06-07)
The nonionic surfactant of sorbitan trioleate (Span 85) was modified with Cibacron Blue F-3GA (CB) as an affinity surfactant (CB-Span 85) to form affinity-based reversed micelles in n-hexane. The reversed micelles formed by the mixture of Span 85 and CB-Span
Jitender Madan et al.
Yao xue xue bao = Acta pharmaceutica Sinica, 42(8), 905-910 (2007-10-20)
The aim is to evaluate the effect of ciprofloxacin and chloramphenicol on anti-BSA antibody production triggered by bovine albumin encapsulated in non-ionic surfactant vesicle, niosomes. Reverse phase evaporation method was adopted to entrap the antigen in colloidal carrier composed of
R N Dalby et al.
Pharmaceutical research, 5(1), 36-39 (1988-01-01)
The delivery of particles as small as possible (preferably less than 5 microns) to the respiratory tract should be the aim of those formulating metered dose inhalers (MDIs). This may be facilitated by the formulation of solution, rather than suspension-type
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico